349735 <common-name>(2s,3s,4s,5r)-6-[[2-[(1-benzylpiperidin-4-yl)methyl]-6-methoxy-3-oxo-1,2-dihydroinden-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid</common-name> <description>(2s,3s,4s,5r)-6-[[2-[(1-benzylpiperidin-4-yl)methyl]-6-methoxy-3-oxo-1,2-dihydroinden-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a chemical compound with the formula C29H35NO9. With an average molecular weight of 541.60 g/mol, (2s,3s,4s,5r)-6-[[2-[(1-benzylpiperidin-4-yl)methyl]-6-methoxy-3-oxo-1,2-dihydroinden-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>154699625</pubchem-id> <chemical-formula>C29H35NO9</chemical-formula> <weight>541.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T14:24:49Z</created-at> <updated-at type="dateTime">2026-08-31T14:24:49Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC5C(C(C(C(O5)C(=O)O)O)O)O</moldb-smiles> <moldb-formula>C29H35NO9</moldb-formula> <moldb-inchi>InChI=1S/C29H35NO9/c1-37-21-13-18-12-19(11-16-7-9-30(10-8-16)15-17-5-3-2-4-6-17)23(31)20(18)14-22(21)38-29-26(34)24(32)25(33)27(39-29)28(35)36/h2-6,13-14,16,19,24-27,29,32-34H,7-12,15H2,1H3,(H,35,36)/t19?,24-,25-,26+,27-,29?/m0/s1</moldb-inchi> <moldb-inchikey>GUJDLRRGLWFUSI-OWECDQGASA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">541.2311817</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>0.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM345628</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(2s,3s,4s,5r)-6-[[2-[(1-benzylpiperidin-4-yl)methyl]-6-methoxy-3-oxo-1,2-dihydroinden-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0300058</sync-id> <structure-inchikey>GUJDLRRGLWFUSI-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000000000080000000000000000090000000000800000201400040000008000000002000000000a00000000400000000000000000000000040000000080002000000000000000000000000102080000000038000000000000000000000800081000000004000800010000000000002010000008000000000000010000400004024000080000000000000000000000000010000000008040044000000000000001400000004000008000000000005000000000000810000000000008000000000000000001000000000000000c010000000000000000220041000010000000000000000000040000000000440000010000020000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkBo AAAAAwMBBgBgAAAAAgIGAGAAAAADAQYAKAAAAAMECAAoAAAAAwIGAGAAAAAC AgYAYAAAAAMBBgBgAAAAAgIGAGAAAAACAgcAIAAAAAMGAGAAAAACAgYAYAAA AAICBgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAwEGAGAAAAADAQYA YAAAAAMBBgBgAAAAAwEGAGAAAAADAQgAIAAAAAIGACgAAAADBAgAKAAAAAMC CABoAAAAAwEBCABgAAAAAQEIAGAAAAABAQgAYAAAAAEBCwABAAECIAIDaAwD BGgMBAVoDAUGaAwGB2gMBggACAkACQoACgsoAgkMAAwNAA0OAA4PAA8QABAR ABESABATABMUABQVaAwVFmgMFhdoDBcYaAwYGWgMAxogGhsAGxwAHB0AHR4A Hh8AHyAAHyEAISIoAiEjIB4kAB0lABwmAAcCaAwKBSASDQAZFGgMIBsAQgUA AAAGAgcGBQQDBQgGBQoJBg4PEBESDQYVFhcYGRQGHB0eHyAbFwQAAAAAAAAA Fg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:47Z</structure-indexed-at> </compound>